Related Experiment Video
Updated: Mar 15, 2026

Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery
Published on: November 14, 2018
Implementation of Intranasal Midazolam for Prolonged Seizures in a Child Neurology Practice
Insights
Intranasal midazolam is an effective treatment for prolonged seizures in children. This project successfully implemented its use in a pediatric neurology practice, significantly increasing prescriptions.
Area of Science:
- Pediatric Neurology
- Emergency Medicine
- Pharmacology
Background:
- Intranasal midazolam is evidence-based for treating prolonged seizures in children.
- Despite proven efficacy, it's not a standard care option.
- Implementation challenges hinder widespread adoption.
Purpose of the Study:
- To implement intranasal midazolam as a rescue medication for prolonged seizures in a pediatric neurology practice.
- To develop a replicable model for other practice sites.
- To assess provider attitudes and usage patterns.
Main Methods:
- Developed a process for intranasal midazolam availability.
- Created an educational intervention for healthcare providers.
- Conducted provider surveys on attitudes and prescribing frequency.
Main Results:
- Successfully integrated intranasal midazolam into practice.
- Observed a significant increase in intranasal midazolam prescriptions.
- Provider surveys indicated a positive shift in attitudes and usage.
Conclusions:
- Implementation of intranasal midazolam as a rescue medication is feasible and effective.
- The developed model can guide other practices in adopting this treatment.
- Increased prescribing demonstrates successful integration into clinical practice.
Abstract:
Currently, evidence supports the use of intranasal midazolam as an effective, and in many cases, preferable treatment option for prolonged seizures in children. Despite this knowledge, intranasal midazolam is not routinely found as a standard of care. The goal of this project was to implement the use of intranasal midazolam as a rescue medication for prolonged seizures within a child neurology practice and, in doing so, create a model for implementation that would be replicable for other practice sites. This project focused on the development of a process to make intranasal midazolam available as a treatment option and then the creation of an educational intervention for providers within a child neurology practice. Provider surveys analyzed provider attitudes toward intranasal midazolam and its frequency of use. Because of this project, a dramatic increase in the prescribing of intranasal midazolam was observed within a child neurology practice.
Related Concept Videos
Parenteral Anesthetics: Overview
Drug Delivery: Enteral Route
Inhalational Anesthetics: Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion

